Fabio R Melo1, Ola Wallerman2, Aida Paivandy2, Gabriela Calounova3, Ann-Marie Gustafson2, Benjamin R Sabari4, Giuliano Zabucchi5, C David Allis4, Gunnar Pejler6. 1. Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. Electronic address: Fabio.Melo@imbim.uu.se. 2. Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. 3. Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden. 4. Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY. 5. Department of Life Sciences, University of Trieste, Trieste, Italy. 6. Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden. Electronic address: Gunnar.Pejler@imbim.uu.se.
Abstract
BACKGROUND: Mast cells are key effector cells in allergic reactions. When activated to degranulate, they release a plethora of bioactive compounds from their secretory granules, including mast cell-restricted proteases such as tryptase. In a previous study, we showed that tryptase, in addition to its intragranular location, can be found within the nuclei of mast cells where it truncates core histones at their N-terminal ends. OBJECTIVE: Considering that the N-terminal portions of the core histones constitute sites for posttranslational modifications of major epigenetic impact, we evaluated whether histone truncation by tryptase could have an impact on epigenetic events in mast cells. METHODS: Mast cells were cultured from wild-type and tryptase null mice, followed by an assessment of their profile of epigenetic histone modifications and their phenotypic characteristics. RESULTS: We show that tryptase truncates nucleosomal histone 3 and histone 2B (H2B) and that its absence results in accumulation of the epigenetic mark, lysine 5-acetylated H2B. Intriguingly, the accumulation of lysine 5-acetylated H2B was cell age-dependent and was associated with a profound upregulation of markers of non-mast cell lineages, loss of proliferative control, chromatin remodeling as well as extensive morphological alterations. CONCLUSIONS: These findings introduce tryptase-catalyzed histone clipping as a novel epigenetic regulatory mechanism, which in the mast cell context may be crucial for maintaining cellular identity.
BACKGROUND: Mast cells are key effector cells in allergic reactions. When activated to degranulate, they release a plethora of bioactive compounds from their secretory granules, including mast cell-restricted proteases such as tryptase. In a previous study, we showed that tryptase, in addition to its intragranular location, can be found within the nuclei of mast cells where it truncates core histones at their N-terminal ends. OBJECTIVE: Considering that the N-terminal portions of the core histones constitute sites for posttranslational modifications of major epigenetic impact, we evaluated whether histone truncation by tryptase could have an impact on epigenetic events in mast cells. METHODS: Mast cells were cultured from wild-type and tryptase null mice, followed by an assessment of their profile of epigenetic histone modifications and their phenotypic characteristics. RESULTS: We show that tryptase truncates nucleosomal histone 3 and histone 2B (H2B) and that its absence results in accumulation of the epigenetic mark, lysine 5-acetylated H2B. Intriguingly, the accumulation of lysine 5-acetylated H2B was cell age-dependent and was associated with a profound upregulation of markers of non-mast cell lineages, loss of proliferative control, chromatin remodeling as well as extensive morphological alterations. CONCLUSIONS: These findings introduce tryptase-catalyzed histone clipping as a novel epigenetic regulatory mechanism, which in the mast cell context may be crucial for maintaining cellular identity.
Authors: Laura Marruecos; Joan Bertran; Daniel Álvarez-Villanueva; María Carmen Mulero; Yolanda Guillén; Luis G Palma; Martin Floor; Anna Vert; Sara Arce-Gallego; Irene Pecharroman; Laura Batlle; Jordi Villà-Freixa; Gourisankar Ghosh; Anna Bigas; Lluís Espinosa Journal: EMBO Rep Date: 2021-07-05 Impact factor: 9.071
Authors: Sultan Alanazi; Mirjana Grujic; Maria Lampinen; Ola Rollman; Christian P Sommerhoff; Gunnar Pejler; Fabio Rabelo Melo Journal: Int J Mol Sci Date: 2020-07-17 Impact factor: 5.923
Authors: Dylan Krajewski; Edwin Kaczenski; Jeffrey Rovatti; Stephanie Polukort; Chelsea Thompson; Catherine Dollard; Jennifer Ser-Dolansky; Sallie S Schneider; Shannon R M Kinney; Clinton B Mathias Journal: Front Immunol Date: 2018-10-23 Impact factor: 7.561